Literature DB >> 8053688

Direct affinity purification and supramolecular organization of human lysosomal cathepsin A.

A V Pshezhetsky1, M Potier.   

Abstract

Cathepsin A (also named "protective protein" and carboxypeptidase L) stabilizes beta-galactosidase and activates neuraminidase by forming with them a high-molecular-weight lysosomal complex. We determined the main forms of the supramolecular organization of human placental cathepsin A and the quantitative relationship between them, using an affinity chromatography on agarose-Phe-Leu for direct purification of cathepsin A. We found that cathepsin A in human placenta exists as the following three forms: a 1270-kDa complex with beta-galactosidase and neuraminidase (about 1% of total cathepsin A), a 680-kDa complex with beta-galactosidase (30-40% of total), and a free 98-kDa cathepsin A dimer (60-70% of total). All forms are in dynamic equilibrium with each other, but almost all placental beta-galactosidase is associated with cathepsin A in the 680-kDa complex. The main properties of free cathepsin A (including the capacity to associate with beta-galactosidase) were found to be identical to those of cathepsin A obtained by dissociation of the 680-kDa complex. The presence of a free cathepsin A pool in the lysosome is connected with its sixfold overproduction in the cell compared to beta-galactosidase and may be necessary to ensure cathepsin A proteolytic function in addition to its protective role for beta-galactosidase and neuraminidase in the lysosomal multienzymatic complex. Such a dual function of cathepsin A is also confirmed by our finding that it is the only carboxypeptidase of placenta extract able to catalyze the hydrolysis of both carbobenzoxy (CBZ)-Glu-Tyr and CBZ-Phe-Leu dipeptide substrates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053688     DOI: 10.1006/abbi.1994.1359

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation.

Authors:  M V Vinogradova; L Michaud; A V Mezentsev; K E Lukong; M El-Alfy; C R Morales; M Potier; A V Pshezhetsky
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.

Authors:  A van der Spoel; E Bonten; A d'Azzo
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

3.  Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.

Authors:  Jose Condori; Walter Acosta; Jorge Ayala; Varun Katta; Ashley Flory; Reid Martin; Jonathan Radin; Carole L Cramer; David N Radin
Journal:  Mol Genet Metab       Date:  2015-12-08       Impact factor: 4.797

4.  Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor.

Authors:  Ana Maria Cuervo; Linda Mann; Erik J Bonten; Alessandra d'Azzo; J Fred Dice
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

5.  Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis.

Authors:  Y Okamura-Oho; S Zhang; W Hilson; A Hinek; J W Callahan
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

6.  Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

Authors:  Ida Annunziata; Alessandra d'Azzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-12-14       Impact factor: 0.694

7.  Structure of the murine lysosomal multienzyme complex core.

Authors:  Alexei Gorelik; Katalin Illes; S M Naimul Hasan; Bhushan Nagar; Mohammad T Mazhab-Jafari
Journal:  Sci Adv       Date:  2021-05-12       Impact factor: 14.136

8.  Co-Expression of NEU2 and GBA3 Causes a Drastic Reduction in Cytosolic Sialyl Free N-glycans in Human MKN45 Stomach Cancer Cells-Evidence for the Physical Interaction of NEU2 and GBA3.

Authors:  Li Wang; Junichi Seino; Haruna Tomotake; Yoko Funakoshi; Hiroto Hirayama; Tadashi Suzuki
Journal:  Biomolecules       Date:  2015-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.